Tenders Are Invited For Deliveries Of Parental Cytostatics To The Hospital Pharmacy

Contract Notice: Deliveries Of Parental Cytostatics To The Hospital Pharmacy Pharmaceutical Products Short Description: The Delivery Of The Following Selection Of Parenteral Cytostatics To The Hospital Pharmacy: -Pelle 1: Arsenic Trioxide For Intravenous Use -Pelle 2: Azacitidine For Subcutaneous Use -Pelle 3: Amsacrine For Intravenous Use -Pelle 4: Bendamustine For Intravenous Use -Pelle 5: Belantamab Mafodotin For Intravenous Use -Pell 6: Bleomycin For Intravenous Use -Peller 7: Brentuximab-Vedotin For Intravenous Administration -Peller 8: Cabazitaxel For Intravenous Administration -Pelle 9: Carboplatin For Intravenous Administration -Pell 10: Carfilzomib For Intravenous Administration -Peller 11: Cisplatin For Intravenous Administration -Pelle 12: Cladribine For Intravenous Administration -Pelle 13: Cladribine For Subcutaneous Administration -Pelle 14: Cyclophosphamide For Intravenous Administration -Pell 15: Cytarabine For Intravenous Administration -Pell 16: Cytarabine 20 Mg/Ml For Intrathecal Administration -Pell 17: Daunubicin For Intravenous Administration -Pell 18: Dacarbazine For Intravenous Administration -Pectal 19: Decitabine For Intravenous Administration -Pell 20: Docetaxel For Intravenous Administration -Pecte 21: Doxorubicin For Intravenous Administration -Pectal 22: Doxorubicin In Pegylated Lipopsoms For Intravenous Administration -Pello 23: Epirubicin For Intravenous Administration -Pelle 24: Eribulin For Intravenous Administration -Pectal 25: Etoposide For Intravenous Administration -Pelle 26: Fludarabine For Intravenous Administration -Pecte 27: Fluorouracil For Intravenous Administration -Pectel 28: Gemcitabine For Intravenous Administration -Pelle 29: Gemtuzumab Ozogamicin For Intravenous Administration -Peller 30: Idarubicin For Intravenous Administration -Pelle 31: Ifosfamide For Intravenous Administration -Pect 32: Inotuzumab Ozogamicin For Intravenous Administration -Pell 33: Irinotecan For Intravenous Administration -Pelle 34: Irinotecan In Pegylated Lipopsoms For Intravenous Administration -Pell 35: Melfalan For Intravenous Administration -Pell 36: Methotrexate 25 Mg/Ml For Intravenous Administration -Pect 37: Methotrexate 100 Mg/Ml For Intravenous Administration -Pell 38: Methotrexate Low -Dose (2.5 Mg/Ml) For Intrathecale Administration -Pelle 39: Mitomycin For Intravenous Administration -Pectal 40: Mitoxantron For Intravenous Administration -Pelle 41: Nelarabine For Intravenous Administration -Pelle 42: Oxaliplatin For Intravenous Administration -Pelle 43: Paclitaxel For Intravenous Administration -Pelle 44: Paclitaxel Albumin For Intravenous Administration -Pell 45: Pegaspargase For Intravenous Administration -Pelle 46: Pemetrexed For Intravenous Administration -Pelle 47: Raltitrexed For Intravenous Administration -Pelle 48: Thiiotpa For Intravenous Administration -Pelle 49: Topotecan For Intravenous Administration -Plot 50: Trabectedin For Intravenous Administration -Pectel 51: Trastuzumab Emtansine For Intravenous Administration -Pell 52: Vinblastine For Intravenous Administration -Pectel 53: Vincristine For Intravenous Administration -Pectel 54: Findesine For Intravenous Administration -Pell 55: Vinorelbine For Intravenous Administration Deadline For Submission: 20220923 10:00 Type Of Buyer: Other Type Of Contract: Supplies Type Of Procedure: Competitive Procedure With Negotiation Regulation: European Union Type Of Bid: Submission For All Lots Award Criteria: The Most Economic Tender [Disclaimer: The Above Text Is Machine Translated. For Accurate Information Kindly Refer The Original Document.] Tender Link : Https://Ted.Europa.Eu/Udl?Uri=Ted:Notice:440514-2022:Data:En:Html